Watchdog Group Blasts FDA’s Dwindling Oversight Of Non-Clinical Labs
This article was originally published in The Gray Sheet
A nonprofit government watchdog group is criticizing FDA for scaling back inspections of laboratories that test medical devices early in the development process, before they are tested in humans
You may also be interested in...
Device industry experts say a seemingly minor footnote to the recent 510(k) program draft guidance could create a new requirement for nonclinical studies.
FDA Science Board members recommend a nearly $1.9 billion direct appropriation for the agency in fiscal 2009, a $375 million increase over 2008, and larger increases in each of the following five federal budgets
Dr Reddy's is poised to expand its OTC offering in Russia and certain CIS countries by snapping up a basket of allergy brands from fellow Indian firm Glenmark.